Found (307) clinical trials

If you are experiencing any of the symptoms of depression, you may qualify to participate in a research study. Meridien Research is currently seeking individuals who are depressed to participate in a research study. Please call 863-940-2087 for more information.

The purpose of this research study is to investigate brain changes in adolescents who are currently experiencing depressive and/or anxiety symptoms and have a family history of bipolar disorder. Participants will be randomized to escitalopram and psychotherapy or placebo and psychotherapy for 16-week treatment.

California Neuroscience Research is conducting a research study to evaluate an investigational medication in persons with treatment resistant Major Depressive Disorder. Study Description A Randomized, Double-blind, Active- controlled Trial to Assess the Efficacy and Safety of Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder.

Clinical Trials of Texas, Inc. is conducting a research study of an investigational medication for adolescent major depressive disorder. Qualified participants receive study-related medical care from a board-certified physician, exams and evaluations.

The PPD-202 Trial is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study evaluating the efficacy, safety and pharmacokinetics of SAGE-547 Injection in the treatment of adult female subjects with severe postpartum depression.

Major Depressive Disorder (MDD) can be a long-term illness, with many patients experiencing relapse. Clinical Trials of Texas, Inc. is currently enrolling patients for a new study to evaluate the relapse prevention effects of an FDA-approved study medication on patients with MDD. Those that participate will receive testing, examinations, study ...